News

The Vienna-based deep-tech TU Wien spin-off will accelerate international commercialization of the world’s first...

FUJIFILM invests in VALANX Biotech to advance next generation therapeutics.

Factory planning has historically been constrained by time, manual effort, and limited iteration. Each layout represents...

From Science to Company Building

Autonomous systems must operate in environments that are complex, dynamic, and unpredictable. Testing these systems in...

XISTA Science Ventures portfolio company Vitrealab Closes $11 Million Series A to Accelerate Development of Quantum...

Augmented reality has long been constrained by hardware — particularly the light engine, where size, efficiency, and...

Turning scientific research into scalable companies remains one of the central bottlenecks in life sciences. The...

Rapid diagnostics have become a cornerstone of modern healthcare — accessible, fast, and scalable. Yet their limitations...

A significant portion of critical infrastructure lies underwater — yet remains difficult to inspect and monitor.

Most advanced AI models are designed for centralized infrastructure. But many applications — from vehicles to edge...

Strong life sciences investments require more than capital — they depend on deep scientific and industry expertise...

At xista, we are building while growing: Expanding our team, launching new ventures, forming strategic partnerships, and...

Syntropic Medical has announced the launch of a groundbreaking clinical study testing a new non-invasive brain...

ReCatalyst, a xista portfolio company pioneering next-generation nanocatalysts for the hydrogen economy, has announced...